| Literature DB >> 35934806 |
Akinao Kaneta1, Takahiro Sato1, Hiroshi Nakano1, Takuro Matsumoto1, Takeshi Tada1, Yohei Watanabe1, Hiroyuki Hanayama1, Suguru Hayase1, Zenichiro Saze1, Koji Kono1.
Abstract
BACKGROUND: Postoperative pneumonia is one of the major complications after esophagectomy. The aim of this study was to determine whether bacterial cultures before esophagectomy could predict occurrence of postoperative pneumonia and help treatment strategies for postoperative pneumonia.Entities:
Keywords: bacterial culture; esophageal carcinoma; esophagectomy; pneumonia
Mesh:
Year: 2022 PMID: 35934806 PMCID: PMC9493340 DOI: 10.5387/fms.2022-09
Source DB: PubMed Journal: Fukushima J Med Sci ISSN: 0016-2590
Patients’ characteristics and surgical outcomes
| Preoperative bacterial culture | |||
| Negative | Positive | ||
| ( | ( | ||
| Age† | 68 ± 8.3 | 69 ± 6.6 | 0.63 |
| Sex (male/female) | 37/12 | 19/1 | 0.09 |
| Brinkman index† | 500 ± 443 | 727 ± 446 | 0.058 |
| %VC† | 100 ± 15 | 103 ± 20 | 0.59 |
| FEV1 (L)† | |||
| Male | 2.79 ± 0.53 | 2.65 ± 0.74 | 0.30 |
| Female | 2.05 ± 0.67 | 1.83 | 0.59 |
| FEV1%† | 74 ± 8.2 | 72 ± 6.0 | 0.35 |
| Comorbidity | |||
| COPD | 8 | 3 | 0.60 |
| Diabetes mellitus | 8 | 3 | 0.60 |
| CONUT score | 0.37 | ||
| Normal (0-1) | 20 | 8 | |
| Light malnutrition (2-4) | 28 | 10 | |
| Moderate malnutrition (5-8) | 1 | 2 | |
| Location of tumor | 0.86 | ||
| Ut | 9 | 3 | |
| Mt | 24 | 8 | |
| Lt | 10 | 6 | |
| Ae | 6 | 3 | |
| Histological type | 0.90 | ||
| Squamous cell carcinoma | 38 | 7 | |
| Adenocarcinoma | 6 | 10 | |
| Others | 5 | 3 | |
| Neoadjuvant therapy | 0.17 | ||
| None | 21 | 7 | |
| Neoadjuvant chemotherapy | 13 | 10 | |
| Neoadjuvant chemoradiotherapy | 15 | 3 | |
| Thoracic surgical approach | 1.0 | ||
| Open | 13 | 5 | |
| MIE | 36 | 15 | |
| 3-field lymphadenectomy | 33 | 12 | 0.58 |
| Operative duration (minutes)† | 529 ± 96 | 571 ± 103 | 0.11 |
| Blood loss (g)† | 283 ± 417 | 390 ± 545 | 0.67 |
| pStage | 0.60 | ||
| 0, I | 16 | 3 | |
| II | 15 | 9 | |
| III | 12 | 5 | |
| IV | 6 | 3 | |
| Anastomotic leakage | 18 | 8 | 0.79 |
| Recurrent laryngeal nerve palsy | 12 | 6 | 0.76 |
| Dysphagia | 13 | 7 | 0.37 |
| Postoperative pneumonia | 12 | 10 |
|
| Severe postoperative pneumonia (≥ IIIa) | 5 | 8 |
|
†Plus-minus values are means ± standard deviation.
%VC, vital capacity as percent of predicted; FEV1, forced expiratory volume in 1 second; FEV1%, forced expiratory volume % in 1 second; COPD, chronic obstructive pulmonary disease; CONUT, controlling nutritional status; Ut, upper thoracic esophagus; Mt, middle thoracic esophagus; Lt, lower thoracic esophagus; Ae, abdominal esophagus; MIE, minimally invasive esophagectomy.
Detection rate of pathogenic bacteria in preoperative bacterial cultures
| Positive rate | ||
| Sputum | 10/45 | (22%) |
| Nasal swab | 11/58 | (18%) |
| Oral swab | 3/56 | (5.3%) |
| Pharyngeal swab | 1/9 | (11%) |
Fig. 1.Number of pathogenic bacterial species detected in pre- and postoperative bacterial cultures.
Logistic regression analysis for postoperative pneumonia
| Variables | Univariate analysis | Multivariate analysis | |||
| OR (95% CI) | OR (95% CI) | ||||
| Age (for 10-year increase) | 0.93 (0.49-1.79) | 0.84 | |||
| Male | 7.20 (0.87-59.4) | 0.067 | |||
| Brinkman index (for 100 increase) | 1.04 (0.93-1.16) | 0.48 | |||
| %VC (for 10% increase) | 0.82 (0.60-1.12) | 0.23 | |||
| FEV1 (for 1 L increase) | 0.87 (0.41-1.86) | 0.72 | |||
| FEV1% (for 10% increase) | 0.39 (0.18-0.85) | 0.018 | 0.31 (0.12-0.76) |
| |
| Comorbidity | |||||
| COPD | 1.26 (0.32-4.89) | 0.72 | |||
| Diabetes mellitus | 0.17 (0.02-1.47) | 0.10 | |||
| CONUT score (normal vs light and moderate malnutrition) | 0.74 (0.26-2.07) | 0.57 | |||
| Neoadjuvant therapy (vs surgery alone) | 2.34 (0.78-7.04) | 0.12 | |||
| Neoadjuvant chemotherapy (vs surgery alone) | 2.82 (0.83-9.57) | 0.096 | |||
| Neoadjuvant chemoradiotherapy (vs surgery alone) | 1.83 (0.48-6.94) | 0.37 | |||
| Thoracic surgical approach (open vs MIE) | 2.92 (0.95-8.94) | 0.06 | |||
| 3-field lymphadenectomy (vs 2-field) | 0.90 (0.31-2.60) | 0.85 | |||
| Operative duration (for 30 minutes increase) | 1.20 (1.02-1.41) | 0.023 | 1.16 (0.96-1.41) | 0.12 | |
| Blood loss (for 50 g increase) | 1.10 (1.01-1.20) | 0.024 | 1.08 (0.98-1.18) | 0.09 | |
| pStage (2-4 vs 0 and 1) | 1.59 (0.49-5.13) | 0.43 | |||
| Anastomotic leakage | 0.92 (0.32-2.62) | 0.87 | |||
| Recurrent laryngeal nerve palsy | 1.48 (0.57-3.84) | 0.41 | |||
| Dysphagia | 2.38 (0.79-7.15) | 0.12 | |||
| Preoperative bacterial culture test (Positive vs Negative) | 3.08 (1.03-9.18) | 0.043 | 2.36 (0.68-8.17) | 0.20 | |
OR, odds ratio; CI, confidence interval; %VC, vital capacity as percent of predicted; FEV1, forced expiratory volume in 1 second; FEV1%, forced expiratory volume % in 1 second; COPD, chronic obstructive pulmonary disease; CONUT, controlling nutritional status; MIE; minimally invasive esophagectomy.
Logistic regression analysis for severe postoperative pneumonia
| Variables | Univariate analysis | Multivariateanalysis | |||
| OR (95% CI) | OR (95% CI) | ||||
| Age (for 10-year increase) | 1.51 (0.65-3.54) | 0.33 | |||
| Male | 3.27 (0.38-27.7) | 0.27 | |||
| Brinkman index (for 100 increase) | 1.07 (0.93-1.22) | 0.31 | |||
| %VC (for 10% increase) | 0.74 (0.51-1.07) | 0.12 | |||
| FEV1 (for 1 L increase) | 0.63 (0.26-1.54) | 0.31 | |||
| FEV1% (for 10% increase) | 0.62 (0.27-1.41) | 0.25 | |||
| Comorbidity | |||||
| COPD | 0.94 (0.17-5.02) | 0.95 | |||
| Diabetes mellitus | 0.38 (0.04-3.29) | 0.38 | |||
| CONUT score (normal vs light and moderate malnutrition) | 1.11 (0.32-3.84) | 0.86 | |||
| Neoadjuvant therapy (vs surgery alone) | 1.11 (0.32-3.84) | 0.86 | |||
| Neoadjuvant chemotherapy (vs surgery alone) | 1.27 (0.31-5.10) | 0.72 | |||
| Neoadjuvant chemoradiotherapy (vs surgery alone) | 0.92 (0.19-4.43) | 0.91 | |||
| Thoracic surgical approach (Open vs MIE) | 3.14 (0.88-11.1) | 0.076 | |||
| 3-field lymphadenectomy (vs 2-field) | 0.82 (0.23-2.85) | 0.75 | |||
| Operative duration (for 30 minutes increase) | 1.26 (1.04-1.52) |
| 1.27 (1.01-1.51) |
| |
| Blood loss (for 50 g increase) | 1.06 (1.00-1.13) |
| |||
| pStage (2-4 vs 0 and 1) | 2.60 (0.52-13.0) | 0.24 | |||
| Anastomotic leakage | 1.54 (0.45-5.22) | 0.48 | |||
| Recurrent laryngeal nerve palsy | 1.08 (0.34-3.43) | 0.88 | |||
| Dysphagia | 1.21 (0.32-4.62) | 0.77 | |||
| Preoperative bacterial culture test (Positive vs negative) | 5.86 (1.61-21.2) |
| 5.03 (1.31-19.2) |
| |
OR, odds ratio; CI, confidence interval; %VC, vital capacity as percent of predicted; FEV1, forced expiratory volume in 1 second; FEV1%, forced expiratory volume % in 1 second; COPD, chronic obstructive pulmonary disease; CONUT, controlling nutritional status; MIE; minimally invasive esophagectomy.